Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105622544A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105622544A details a one-step Rh-catalyzed route to N-sulfonyl-3,4-dihydro-2H-1,4-thiazine, offering streamlined manufacturing and high purity for pharmaceutical intermediates.